x
ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2023 > 9th ESO Prostate Cancer Observatory: Innovation and Care in the next 12 months
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

9th ESO Prostate Cancer Observatory: Innovation and Care in the next 12 months

Not eligible for ESCO credits

10.03.2023

Milan, IT

OBSERVATORY

Prostate cancer

Description

Chairs: U. Vogl, CH - M. Salmon, IT

12:30 – 14:45
Yellow Area, Brown 3

The European School of Oncology is pleased to announce the 9th edition of "ESO Prostate Cancer Observatory: innovation and care in the next 12 months", which will be held during the EAU223 Congress (10-13 March 2023)

AIMS AND OBJECTIVES

ESO Observatories are high level sessions organised during major international congresses with the aim of providing the audience with updated and unbiased information on a given topic. An ESO Observatory lasts about two hours and concentrates on a forecast given by panel of experts of what it is expected to happen in their own field in the coming 12 months. The Panel includes distinguished clinicians and/or scientists a patient advocate and a nurse.
The forecast by each Panel Member is given in the form of concise take-home messages with a 8 minutes slide presentation followed by a 2 minutes interactive discussion for each topic.

The Observatory will be held during the

Programme

10 March

12:30 Welcome and Introduction from Chairs
Mario Salmon, IT - Ursula Vogl, CH
12:35 The urologist’s perspective on surgery
Steven Joniau, BE
12:45 The urologist’s perspective on active surveillance
Philip Cornford, UK
12:55 The radiation oncologist’s perspective
Gert De Meerleer, BE
13:05 The medical oncologist’s perspective
Ursula Vogl, CH
13:15 The pathologist’s perspective
Eva Compérat, AT
13:25 The geneticist’s perspective
Elena Castro, ES
13:35 The imaging specialist’s perspective on PSMA-PET/CT
Stefano Fanti, IT
13:45 The imaging specialist’s perspective on MRI
Jelle Barentsz, NL
13:55 The urologist’s perspective on focal therapy
Rafael Sanchez Salas, CA
14:05 The nurse’s perspective
Corinne Tillier, NL
14:15 The patient’s perspective
Mario Salmon, IT
14:25 Closing remarks

 

Faculty

Jelle Barentsz, Radboud UMC, Radiology and Nuclear Medicine Dept., Nijmegen, NL
Elena Castro, Hospital Universitario Virgen de la Victoria, Oncology Dept, Málaga, ES
Eva Compérat, Tenon Hospital, Pathology Dept., Paris, FR
Philip Cornford, Liverpool University UK L7 8XP, Dept of Urology, Liverpool, UK
Gert De Meerleer, Gent University, Dept. of Radiotherapy, Gent, BE
Stefano Fanti, Policlinico S.Orsola, PAD 30, Bologna, IT
Steven Joniau, University Hospitals Leuven, Dept. of Urology, Leuven, BE
Mario Salmon, Europa Uomo Italia Onlus, Pazienti, Milano, IT
Rafael Sanchez Salas, McGill University. Montréal, Québec., Stephen Jarislowsky - Chair or Urology, Montreal, CA
Corinne Tillier, Netherlands Cancer Institute, Urology Dpt., Amsterdam, NL
Ursula Vogl, Cantonal Hospital of Southern Switzerland (EOC), IOSI - Oncology Institute of Southern Switzerland, Bellinzona, CH